Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Radient Restructured By A Planned Reverse Merger


We have concluded from the planned merger between Radient and Provista Diagnostics according to the LOI of 2010 and our completed analysis that Provista Diagnostics will either merge with Radient or reverse triangular merge Global Cancer Diagnostics with Radient.
The agreement between AMDL Diagnostics and Uni-Pharma and the agreement between Radient and Global Cancer Diagnostics were set up on a temporary basis and conveniently terminated after the last patent expired. Radient and Provista Diagnostics still have an exclusive 5 year agreement in force and Radient and Uni-Pharma are also in an exclusive and existing five year agreement. Those two agreements superseded the two previously terminated agreements. The Lung Cancer Test a/k/a LC Sentinel is still owned by Radient and Provista Diagnostics and included in their 5 year exclusive and collaborated agreement from November 2010 to research, develop, and commercialize cancer tests including the Lung Cancer Test. William Gartner sold his lung cancer and breast cancer to Provista Diagnostics in 2011.
The 4.5 billion RXPC shares outstanding are held by Institutional investors who had converted their debt for equity, and Angel investors who we believe are associated with Provista Diagnostics. After the announcement of revocation and insolvency, RXPC shares were accumulated and not sold. During the 2012 to July 3, 2014 period of trading,the creeping take over groups quietly took all the shares that Radient released slowly and in a timely manner to the public. If "ebabies" retailers etc that some are calling them were buying,they would have been the first to sell shares. As you can see from the lack of interest on this board before 2012 and after 2013...Enjoy our deductive logic approach to our premisses....

"Radient Is Being Restructured By A Planned Reverse Merger."

If:Radient wants and needs to be restructured by a merger and not by bankruptcy.

Then:Provista Diagnostics wants to go public

Therefore:Provista Diagnostics will merge according to the planned merger LOI of 2010 and the planned restructuring of Radient


*Uni-Pharma-Radient Dx Current Agreements and Past Agreement

http://finance.yahoo.com/news/Radient-Pharmaceuticals-iw-2457187542.html

http://contractservices.pharmaceutical-business-review.com/news/radient-expands-distribution-agreement-with-unipharma-221211

http://www.sec.gov/Archives/edgar/data/838879/000121390013003078/f8k061113ex10i_radientpharm.htm


*Radient Dx and Provista-Global Cancer Dx Current Agreements

http://www.marketwired.com/press-release/Radient-Pharmaceuticals-Announces-Exclusive-5-Year-Laboratory-Services-Agreement-With-NYSE-Amex-RPC-1345331.htm

http://www.sec.gov/Archives/edgar/data/838879/000114420412039787/v318772_ex10-1.htm

*Radient Dx and Provista DX /Global Cancer DX Lung Cancer Test

http://www.pharmaceuticalonline.com/doc/radient-pharmaceuticals-and-provista-life-0001

http://www.bizjournals.com/phoenix/print-edition/2011/12/30/provista-to-go-public-with-breast.html

http://www.biocentury.com/products/lc_sentinel


*Over 38 Million Dollars Lender Debt Converted to Stock

http://www.prnewswire.com/news-releases/radient-pharmaceuticals-corporation-completes-restructurings-with-institutional-investors-to-limit-conversions-and-stock-sales-and-provide-for-potential-additional-capital-134659763.html

http://www.sec.gov/Archives/edgar/data/838879/000114420411050187/v233664_8k.htm

http://www.sec.gov/Archives/edgar/data/838879/000114420411050187/v233664_ex10-1.htm

http://www.sec.gov/Archives/edgar/data/838879/000114420411050187/v233664_ex10-2.htm

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112765409

http://seekingalpha.com/instablog/424698-m-e-garza/177461-regarding-latest-8k-filing-by-radient-pharmaceuticals-rpc

*All Accounts Payable Paid in Full By GCDx and Uni-Pharma Royalties/ License Agreements,Onko-Sure Sales in India,Taiwan,Korea,etc.and Attorney Debt to Equity Agreement

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112733314

*SRL Limited and Metropolis Healthcare Currently Selling Onko-Sure/Cancer 8 Throughout India

http://www.west-info.eu/it/analisi-del-sangue-13-tipi-tumore-cancro/2012-02-onkosure-fibrin-fdp-in-cancer-mm-2/

http://www.metropolisindia.com/patients/cancer-eight


*Institutional Shareholders

http://www.prnewswire.com/news-releases/radient-pharmaceuticals-corporation-completes-restructurings-with-institutional-investors-to-limit-conversions-and-stock-sales-and-provide-for-potential-additional-capital-134659763.html

http://www.sec.gov/Archives/edgar/data/838879/000121390012000035/0001213900-12-000035-index.htm

http://www.sec.gov/Archives/edgar/data/838879/000121390012002920/sc13g052112whale_radient.htm

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=7538329

http://msnmoney.brand.edgar-online.com/DisplayFilingInfo.aspx?TabIndex=2&FilingID=7717117&type=html&companyid=4985&ppu=%2fDefault.aspx%3fticker%3drpc

http://www.sec.gov/Archives/edgar/data/838879/000136456011000007/stgeo_sc13g.htm

http://www.sec.gov/Archives/edgar/data/838879/000101968711002819/bristol_13ga-082411.htm

http://www.sec.gov/Archives/edgar/data/838879/000121390011003768/sc13g0711a1whale_radient.htm

http://www.sec.gov/Archives/edgar/data/838879/000121390011003763/sc13g0711a1alpha_radient.htm

http://www.sec.gov/Archives/edgar/data/838879/000090266411001142/p11-1347sc13g.htm

http://www.sec.gov/Archives/edgar/data/838879/000101968712000550/bristolradient_13ga2.htm

http://www.sec.gov/Archives/edgar/data/838879/000119312512059770/d301526dsc13ga.htm

http://www.sec.gov/Archives/edgar/data/838879/000090266412000289/p12-0319sc13ga.htm

Conclusion:

http://provistadx.com/

http://globalcancerdx.com/

http://azbio.tv/video/76134461f30e472d8f08be36f73bc095

http://seekingalpha.com/instablog/8702411-underdawg/2186492-the-many-veils-of-radient-pharmaceuticals-onko-sure-drminus-70

The link below will guide you to the complete analysis to our premisses.

"Radient Restructured By A Planned Reverse Merger"

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113309714